Campbell Rogers , MD

CTO

Cordis
Warren, NJ

Campbell Rogers, M.D., is Chief Technology Officer (CTO) of the Cordis Corporation. Dr. Rogers directs the company?s scientific and technical agenda and is responsible for leading investments and research in innovative cardiovascular and peripheral vascular technologies. Prior to joining Cordis, Dr. Rogers was Associate Professor of Medicine, Harvard Medical School in Cambridge, Mass and a faculty member in the Harvard-MIT Division of Health Sciences and Technology in Cambridge, Mass. He also was Director, Cardiac Catheterization Laboratory (CCL), Cardiovascular Division, Brigham and Women?s Hospital in Boston, Mass, where he oversaw all aspects of CCL activity, including faculty practice, clinical care, medical student, resident and cardiology fellow education, and clinical research. As Principal Investigator of Brigham and Women?s comprehensive interventional vascular biology laboratory, Dr. Rogers has led work used for clinician education worldwide on the use of novel devices preceding clinical application. He also has extensive experience as a National Principal Investigator and Co-investigator of multi-center device and pharmacologic trials based in the cardiac catheterization lab. Dr. Rogers also has been a Clinical Associate, Massachusetts General Hospital, and served as a Research Associate, Veteran?s Administration Medical Center, Mass. Dr. Rogers is the author of numerous journal articles in the area of cardiovascular disease and is the recipient of many academic society honors. He has been a visiting physician to various institutions in Beijing, China, Brazil, and Hong Kong. Dr. Rogers graduated from Harvard College. He then attended Clare College in Cambridge, England, and received his medical degree from Harvard Medical School.